There is increasing use of neuroimaging modalities, including PET, for diagnosing
dementia. For example, FDG-PET demonstrates hypometabolic regions in the posterior …

Objectives The aim of this article was to review the current role of brain PET in the diagnosis
of Alzheimer dementia. The characteristic patterns of glucose metabolism on brain FDG-PET …

OBJECTIVE. In this article, we review the literature on PET/CT in the management of
dementia, present evidence for best clinical practices, and discuss recent advances in the …

OBJECTIVE. We review the role of brain FDG PET in the diagnosis of Alzheimer disease,
frontotemporal dementia, dementia with Lewy bodies, and vascular dementia. Characteristic …

Clinical use of positron emission tomography (PET) is now well established in
neurodegenerative disorders, especially in the diagnosis of dementia. Measurement of …

The purpose of this article is to present a selective and concise summary of
fluorodeoxyglucose (FDG) positron emission tomography (PET) in dementia imaging. FDG …

Abstract Current Positron Emission Tomography (PET) biomarkers for Alzheimer's disease
(AD) assess either neuronal function, or associated pathological features of this common …

Although diagnosing the syndrome of dementia is largely a clinical endeavor, neuroimaging
plays an increasingly important role in accurately determining the underlying etiology, which …

The diagnosis of dementia syndromes can be challenging for clinicians, particularly in the
early stages of disease. Patients with higher education levels may experience a marked …

Dementing illnesses such as Alzheimer's disease (AD) progressively devastate human brain
tissue and consequently the health and lives of people afflicted by these disorders. One of …